|1.||Zurbriggen, Rinaldo: 29 articles (06/2012 - 06/2002)|
|2.||Amacker, Mario: 16 articles (05/2015 - 01/2005)|
|3.||Wilschut, Jan: 16 articles (02/2014 - 02/2002)|
|4.||Pluschke, Gerd: 15 articles (05/2015 - 05/2003)|
|5.||Westerfeld, Nicole: 14 articles (01/2011 - 01/2005)|
|6.||Glück, R: 12 articles (07/2003 - 01/2000)|
|7.||Huckriede, Anke: 10 articles (02/2014 - 02/2002)|
|8.||Zurbriggen, R: 8 articles (02/2010 - 01/2000)|
|9.||Robinson, John A: 7 articles (01/2009 - 05/2003)|
|10.||Moser, Christian: 6 articles (07/2013 - 07/2004)|
|1.||Human Influenza (Influenza)
12/01/2014 - "An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice."
04/01/2015 - "In this study, the potential of virosomes as a delivery system for an influenza T-cell peptide was investigated. "
08/01/2004 - "Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly."
06/01/2002 - "In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus."
01/01/2015 - "Electron microscopic examination of pooled vaccine material demonstrated the presence of typical influenza structures including split virus, virosomes, whole virus particles and agglomerates. "
04/19/2013 - "Importantly, IN immunization with RSV-MPLA virosomes, like live virus infection, did not lead to any signs of ERD upon live virus challenge of vaccinated animals, whereas IM immunization with FI-RSV did induce severe lung immunopathology under otherwise comparable conditions. "
04/19/2013 - "Antibody responses and Th1/Th2-cytokine responses induced by RSV-MPLA virosomes were comparable to those induced by live RSV infection. "
01/01/2013 - "Finally, IN immunization with adjuvanted virosomes, particularly Pam3CSK4/L18-MDP-adjuvanted-virosomes, protected mice against infection with RSV, without priming for enhanced disease. "
03/01/2010 - "However, even at high multiplicities of infection (10 PFU/cell), we estimate approximately 20% of the virosomes never fuse. "
03/01/2010 - "The preparations protected the chickens against virulent virus challenge infection, however the microencapsulated virosome vaccine gave slightly lesser degree of protection than non encapsulated counterpart. "
|3.||Hepatitis A (Hepatitis, Infectious)
12/01/1992 - "Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A."
09/01/2003 - "A single dose of a hepatitis A virosome vaccine is safe and protects young children against HAV infection."
10/01/1996 - "The anti-PE and anti-PC antibody response was determined for human volunteers immunized with a virosome-formulated vaccine against hepatitis A, or a standard or virosome-formulated influenza vaccine. "
03/08/1996 - "The seroconversion rate was measured after application of a new type of vaccine against hepatitis A (immunopotentiating reconstituted influenza virus virosome [IRIV]) in patients who had undergone a splenectomy after trauma. "
09/01/2003 - "In a randomized, double-blind trial of a single dose of a virosome-formulated, aluminum-free inactivated HAV vaccine in Nicaragua, 274 children (age range, 1.5-6 years) received vaccine or placebo injections; 239 children seronegative for hepatitis A were included in the primary efficacy analysis. "
|4.||Influenza in Birds (Avian Flu)
06/01/2012 - "Here we examined the protective efficacy of a virosome-based vaccine consisting of avian influenza virus (AIV) A/Duck/Czech/56/H4N6 in chickens against a homologous AIV challenge. "
06/01/2012 - "Vaccination with CpG-adjuvanted avian influenza virosomes promotes antiviral immune responses and reduces virus shedding in chickens."
02/11/2011 - "Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN."
02/11/2011 - "In this study, we examined the immunogenicity of avian influenza virosomes with or without inclusion of recombinant chicken interferon-gamma (rChIFN-γ) or CpG-ODN in chickens. "
|5.||Melanoma (Melanoma, Malignant)
02/01/2007 - "The results showed that Sendai virosomes-formulated melanoma vaccine can effectively elicit not only systemic immune response but also strong CTL response. "
02/01/2007 - "In this paper, Sendai virosomes-formulated melanoma vaccine was constructed and its anti-tumor effects were investigated. "
02/01/2007 - "The melanoma vaccine was prepared by encapsulating mixture antigen into the Sendai virosomes. "
03/01/2008 - "Two successive groups of 20 resected AJCC stages IIb-IV melanoma patients will be treated, first with melanoma epitopes included into Influenza virosomes (group 1), and second with a heterologous prime-boost protocol priming with a recombinant Vaccinia virus, and boosting with Influenza virosomes (group 2). "
12/01/2005 - "Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro."
|3.||DNA (Deoxyribonucleic Acid)
|4.||Hepatitis A Vaccines (Hepatitis A Vaccine)
|5.||E coli heat-labile enterotoxin
|4.||Highly Active Antiretroviral Therapy (HAART)
|5.||Heterologous Transplantation (Xenotransplantation)